官方公布13个医药广告表演者违法案例,刘洪滨、李炽明在列

2017-07-17 佚名 中新网

国家工商行政管理总局网站消息,近期,有关媒体报道“医药广告表演者”事件后,引发社会关注,为回应社会关切,国家工商总局公布13个前一段时期全国工商和市场监管部门查处的涉及“医药广告表演者”事件的典型案例。天津市广播电视台发布违法广告案。当事人发布“天山雪莲”“明目二十五味丸”等广告。广告利用“刘洪滨”“高振宗”扮演的专家作推荐证明,含有疾病预防和治疗功能的内容,使用医疗用语,含有易与药品相混淆的内容

国家工商行政管理总局网站消息,近期,有关媒体报道“医药广告表演者”事件后,引发社会关注,为回应社会关切,国家工商总局公布13个前一段时期全国工商和市场监管部门查处的涉及“医药广告表演者”事件的典型案例。

天津市广播电视台发布违法广告案。当事人发布“天山雪莲”“明目二十五味丸”等广告。广告利用“刘洪滨”“高振宗”扮演的专家作推荐证明,含有疾病预防和治疗功能的内容,使用医疗用语,含有易与药品相混淆的内容,未经食品药品监管部门审查批准,违反了《广告法》第十八条、第四十六条等规定。2016年5月和2017年4月,天津市和平区市场和质量监督管理局分别作出行政处罚,责令当事人立即停止发布违法广告,分别罚款20万元和1万元。

河北省魏县广播电视台发布违法广告案。当事人发布“唐通5.0”“康谷丹舒筋活络丸”等广告。广告利用“刘洪滨”“李炽明”扮演的专家作推荐证明,含有表示功效的断言保证等违法内容,违反了《广告法》第十六条等规定。2017年5月,河北省魏县市场监督管理局作出行政处罚,责令当事人立即停止发布违法广告,罚款2万元。

河北省秦皇岛市电视台发布违法广告案。当事人发布“明目二十五味丸”广告。广告利用“高振宗”扮演专家作推荐证明,含有表示功效、安全性的断言或者保证,违反了《广告法》第十六条等规定。2016年11月,秦皇岛市食品和市场监督管理局作出行政处罚,责令当事人立即停止发布违法广告,罚款6.2万元。

内蒙古库伦蒙药有限公司发布违法广告案。当事人通过辽宁广播电视台影视剧频道发布“明目二十五味丸”广告。广告利用“高振宗”扮演的专家作推荐证明,含有表示功效、安全性的断言或者保证的内容,违反了《广告法》第十六条等规定。2016年11月,辽宁省工商局作出行政处罚,责令当事人立即停止发布违法广告,罚款1.44万元。

辽宁省北镇市广播电视台发布违法广告案。当事人发布“唐通5.0”广告。广告利用“刘洪滨”扮演的专家作推荐证明,使用医疗用语,含有易与药品相混淆的内容,涉及疾病预防、治疗功能,违反了《广告法》第十七条等规定。2017年4月,辽宁省北镇市市场监督管理局作出行政处罚,责令当事人立即停止发布违法广告,罚款3万元。

吉林省电视台发布违法广告案。当事人发布“明目二十五味丸”广告。广告利用“高振宗”扮演的专家作推荐证明,未经食品药品监管部门审查批准,违反了《广告法》第四十六条等规定。2017年2月,吉林省工商局作出行政处罚,责令当事人立即停止发布违法广告,罚款4.6万元。

山东省兰陵县广播电视台发布违法广告案。当事人发布“唐通5.0”等广告。广告利用“刘洪滨”扮演的专家作推荐证明,含有表示功效的断言或保证等内容,未经食品药品监管部门审查批准,违反了《广告法》第十六条等规定。2017年5月,兰陵县工商局作出行政处罚,责令当事人立即停止发布违法广告,罚款4万元。

山东省泰安市岱岳区广播电视台发布违法广告案。当事人发布“神佗定喘药”等广告。广告利用“李炽明”扮演的专家作推荐证明,含有表示功效、安全性的断言或者保证,说明治愈率、有效率等内容,违反了《广告法》第十六条、第十七条等规定。2017年2月,泰安市泰山区工商局作出行政处罚,罚款14万元。

河南省宜阳县易通信息传媒有限公司发布违法广告案。当事人委托宜阳县电视台发布“康谷丹舒筋活络丸”等广告。广告利用“李炽明”扮演的专家作推荐证明,含有表示功效的断言保证、说明治愈率有效率等违法内容,违反了《广告法》第十六条等规定。2017年6月,河南省宜阳县工商局作出行政处罚,责令当事人停止发布违法广告行为,罚款6.1万元。

湖南省衡南县广播电视台发布违法广告案。当事人发布“唐通5.0”等广告。广告利用“刘洪滨”扮演的专家作推荐证明,未经食品药品监管部门审查批准,违反了《广告法》第十五条、第四十六条等规定。2016年5月,衡南县市场和质量监督管理局作出行政处罚,责令当事人立即停止发布违法广告,罚款20.4万元。

贵州省贵视华广传媒有限公司发布违法广告案。当事人通过贵州广播电视台发布“巴西绿蜂胶”广告。广告利用“刘洪滨”扮演的专家作推荐证明,涉及疾病治疗功能,使用医疗用语,含有易与药品相混淆的内容,违反了《广告法》第十七条、第十八条等规定。2017年3月,贵阳市南明区市场监管局作出行政处罚,罚款8000元。

甘肃省广播电影电视总台(集团)发布违法广告案。当事人在甘肃文化影视频道发布“巴西绿蜂胶”广告。广告利用“刘洪滨”扮演的专家作推荐证明,涉及疾病治疗功能,使用医疗用语,含有易与药品相混淆的内容,利用患者作证明,违反了《广告法》第十七条、第十八条等规定。2017年4月,甘肃省工商局作出行政处罚,责令当事人立即停止发布违法广告,罚款2.45万元。

宁夏广播电视台发布违法广告案。当事人发布“老院长祛斑方”“龙舒泰地龙胶囊”等广告。广告利用“刘洪滨”“李炽明”扮演的专家作推荐证明,广告内容含有表示功效、安全性的断言或保证,涉及疾病预防、治疗功能,违反了《广告法》第十八条等规定。2017年5月,宁夏回族自治区工商局作出行政处罚,责令当事人立即停止发布违法广告,罚款2.4万元。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2053552, encodeId=937c2053552b8, content=<a href='/topic/show?id=d841614397c' target=_blank style='color:#2F92EE;'>#李炽明#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61439, encryptionId=d841614397c, topicName=李炽明)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Fri Jan 19 22:45:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776872, encodeId=6c6b1e7687273, content=<a href='/topic/show?id=3baf9449415' target=_blank style='color:#2F92EE;'>#违法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94494, encryptionId=3baf9449415, topicName=违法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65839047655, createdName=dinorsor537, createdTime=Mon Apr 30 13:45:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408993, encodeId=49bb140899371, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jul 19 12:45:00 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223407, encodeId=b32522340e7f, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Jul 18 06:43:31 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223379, encodeId=f8a42233e901, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Tue Jul 18 06:15:22 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223331, encodeId=3aee2233311c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuBA90ng5ibXMmibn1feGOQ2cjw0S48DKsF0icicFlmRxwHibIic2TNGd22vVqkKRMj2cRSWbpqZAPBPgdt/0, createdBy=81031668757, createdName=林3301, createdTime=Tue Jul 18 00:00:23 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2053552, encodeId=937c2053552b8, content=<a href='/topic/show?id=d841614397c' target=_blank style='color:#2F92EE;'>#李炽明#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61439, encryptionId=d841614397c, topicName=李炽明)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Fri Jan 19 22:45:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776872, encodeId=6c6b1e7687273, content=<a href='/topic/show?id=3baf9449415' target=_blank style='color:#2F92EE;'>#违法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94494, encryptionId=3baf9449415, topicName=违法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65839047655, createdName=dinorsor537, createdTime=Mon Apr 30 13:45:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408993, encodeId=49bb140899371, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jul 19 12:45:00 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223407, encodeId=b32522340e7f, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Jul 18 06:43:31 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223379, encodeId=f8a42233e901, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Tue Jul 18 06:15:22 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223331, encodeId=3aee2233311c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuBA90ng5ibXMmibn1feGOQ2cjw0S48DKsF0icicFlmRxwHibIic2TNGd22vVqkKRMj2cRSWbpqZAPBPgdt/0, createdBy=81031668757, createdName=林3301, createdTime=Tue Jul 18 00:00:23 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2053552, encodeId=937c2053552b8, content=<a href='/topic/show?id=d841614397c' target=_blank style='color:#2F92EE;'>#李炽明#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61439, encryptionId=d841614397c, topicName=李炽明)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Fri Jan 19 22:45:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776872, encodeId=6c6b1e7687273, content=<a href='/topic/show?id=3baf9449415' target=_blank style='color:#2F92EE;'>#违法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94494, encryptionId=3baf9449415, topicName=违法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65839047655, createdName=dinorsor537, createdTime=Mon Apr 30 13:45:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408993, encodeId=49bb140899371, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jul 19 12:45:00 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223407, encodeId=b32522340e7f, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Jul 18 06:43:31 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223379, encodeId=f8a42233e901, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Tue Jul 18 06:15:22 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223331, encodeId=3aee2233311c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuBA90ng5ibXMmibn1feGOQ2cjw0S48DKsF0icicFlmRxwHibIic2TNGd22vVqkKRMj2cRSWbpqZAPBPgdt/0, createdBy=81031668757, createdName=林3301, createdTime=Tue Jul 18 00:00:23 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2017-07-19 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=2053552, encodeId=937c2053552b8, content=<a href='/topic/show?id=d841614397c' target=_blank style='color:#2F92EE;'>#李炽明#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61439, encryptionId=d841614397c, topicName=李炽明)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Fri Jan 19 22:45:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776872, encodeId=6c6b1e7687273, content=<a href='/topic/show?id=3baf9449415' target=_blank style='color:#2F92EE;'>#违法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94494, encryptionId=3baf9449415, topicName=违法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65839047655, createdName=dinorsor537, createdTime=Mon Apr 30 13:45:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408993, encodeId=49bb140899371, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jul 19 12:45:00 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223407, encodeId=b32522340e7f, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Jul 18 06:43:31 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223379, encodeId=f8a42233e901, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Tue Jul 18 06:15:22 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223331, encodeId=3aee2233311c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuBA90ng5ibXMmibn1feGOQ2cjw0S48DKsF0icicFlmRxwHibIic2TNGd22vVqkKRMj2cRSWbpqZAPBPgdt/0, createdBy=81031668757, createdName=林3301, createdTime=Tue Jul 18 00:00:23 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2017-07-18 惠映实验室

    学习了,谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2053552, encodeId=937c2053552b8, content=<a href='/topic/show?id=d841614397c' target=_blank style='color:#2F92EE;'>#李炽明#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61439, encryptionId=d841614397c, topicName=李炽明)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Fri Jan 19 22:45:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776872, encodeId=6c6b1e7687273, content=<a href='/topic/show?id=3baf9449415' target=_blank style='color:#2F92EE;'>#违法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94494, encryptionId=3baf9449415, topicName=违法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65839047655, createdName=dinorsor537, createdTime=Mon Apr 30 13:45:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408993, encodeId=49bb140899371, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jul 19 12:45:00 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223407, encodeId=b32522340e7f, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Jul 18 06:43:31 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223379, encodeId=f8a42233e901, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Tue Jul 18 06:15:22 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223331, encodeId=3aee2233311c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuBA90ng5ibXMmibn1feGOQ2cjw0S48DKsF0icicFlmRxwHibIic2TNGd22vVqkKRMj2cRSWbpqZAPBPgdt/0, createdBy=81031668757, createdName=林3301, createdTime=Tue Jul 18 00:00:23 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2017-07-18 130****4638

    学习了谢谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2053552, encodeId=937c2053552b8, content=<a href='/topic/show?id=d841614397c' target=_blank style='color:#2F92EE;'>#李炽明#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61439, encryptionId=d841614397c, topicName=李炽明)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Fri Jan 19 22:45:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776872, encodeId=6c6b1e7687273, content=<a href='/topic/show?id=3baf9449415' target=_blank style='color:#2F92EE;'>#违法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94494, encryptionId=3baf9449415, topicName=违法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65839047655, createdName=dinorsor537, createdTime=Mon Apr 30 13:45:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408993, encodeId=49bb140899371, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jul 19 12:45:00 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223407, encodeId=b32522340e7f, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Jul 18 06:43:31 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223379, encodeId=f8a42233e901, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Tue Jul 18 06:15:22 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223331, encodeId=3aee2233311c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuBA90ng5ibXMmibn1feGOQ2cjw0S48DKsF0icicFlmRxwHibIic2TNGd22vVqkKRMj2cRSWbpqZAPBPgdt/0, createdBy=81031668757, createdName=林3301, createdTime=Tue Jul 18 00:00:23 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2017-07-18 林3301

    学习了

    0

相关资讯

广电总局:医疗养生类节目未经备案不得播出

日前公布的《国家新闻出版广电总局关于进一步加强医疗养生类节目和医药广告播出管理的通知》(以下简称《通知》)要求,严格医疗养生类节目管理,严格医药广告播出管理,坚决查处各类违法违规行为。其中明确提出:医药广告不得以任何节目形态变相发布,单条广告时长不得超过一分钟,严禁播出任何虚假医药广告。医疗养生类节目只能由电台电视台策划制作,不得由社会公司制作。坚持把社会效益放在首位《通知》指出,医疗养生类节目和